Monthly Archives: May 2006
Major Discovery: New Insulin-Production Method Holds Promise For Diabetics, Impacts Other Fields
A new mechanism for the formation of insulin crystals in the pancreas has been discovered.
Ghrelin: A player in diabetes but not obesity?
Ghrelin, a hormone long considered a key player in obesity, may instead take a major role in maintaining the balance between insulin and glucose and the development of diabetes.
Study: No Evidence of an Additional Therapeutic Benefit of Inhaled Insulin (Exubera)
There is currently no evidence available that inhaled insulin (Exubera) in diabetes therapy shows advantages over short-acting human insulin or insulin analogues administered subcutaneously.
Study: Insulin Signaling Findings May Advance Treatments to Prevent Type 2 Diabetes and Metabolic...
New findings open the door to the development of new treatments that one day may target directly the conditions that contribute to type 2 diabetes and the metabolic syndrome.
Study: Diabetes Hits 275 Australians Each Day As Pandemic Spreads
Australian diabetes epidemic is being driven by lifestyle factors, particularly the dramatic increase in obesity, poor diet and physical inactivity.
Study: Signaling Pathways Required for Expansion of Pancreas Stem Cells
IDDM, which used to be referred to as Type 1 diabetes, results from selective destruction of insulin-producing pancreatic islet beta cells by the body's immune system.
Survey: Some People Would Give Life or Limb Not To Be Fat
Nearly half of the people responding to an online survey about obesity said they would give up a year of their life rather than be fat.
Study: Rates of Serious Diabetes-Related Disorders Not Improving
While cases of premature death and a few other complications have declined, rates of other serious diabetes-related disorders such as heart and eye disease have not improved over the past 25 to 30 years.
